Texas Instruments (TXN) Financials

$183.24 +6.94 (+3.94%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$183.75 +0.51 (+0.28%)

As of 05/27/2025 07:57 PM Eastern

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	4,775	6,477	8,710	7,736	5,568	4,986	5,538	3,649	3,551	2,944
Consolidated Net Income / (Loss)	4,799	6,510	8,749	7,769	5,595	5,017	5,580	3,682	3,595	2,986
Net Income / (Loss) Continuing Operations	4,799	6,510	8,749	7,769	5,595	5,017	5,580	3,682	3,595	2,986
Total Pre-Tax Income	5,453	7,418	10,032	8,919	6,017	5,728	6,686	6,080	4,930	4,216
Total Operating Income	5,465	7,331	10,140	8,960	5,894	5,723	6,713	6,083	4,855	4,322
Total Gross Profit	9,094	11,019	13,771	12,376	9,269	9,164	10,277	9,614	8,257	7,575
Total Revenue	15,641	17,519	20,028	18,344	14,461	14,383	15,784	14,961	13,370	13,000
Operating Revenue	15,641	17,519	20,028	18,344	14,461	14,383	15,784	14,961	13,370	13,000
Total Cost of Revenue	6,547	6,500	6,257	5,968	5,192	5,219	5,507	5,347	5,113	5,425
Operating Cost of Revenue	6,547	6,500	6,257	5,968	5,192	5,219	5,507	5,347	5,113	5,425
Total Operating Expenses	3,629	3,688	3,631	3,416	3,375	3,441	3,564	3,531	3,402	3,253
Selling, General & Admin Expense	1,794	1,825	1,704	1,720	1,647	1,645	1,684	1,694	1,742	1,728
Research & Development Expense	1,959	1,863	1,670	1,554	1,530	1,544	1,559	1,508	1,356	1,267
Restructuring Charge	-124	0.00	257	-	-	-36	321	329	304	258
Total Other Income / (Expense), net	-12	87	-108	-41	123	5.00	-27	-3.00	75	-106
Interest Expense	508	353	214	184	190	170	125	78	80	90
Other Income / (Expense), net	496	440	106	143	313	175	98	75	155	-16
Income Tax Expense	654	908	1,283	1,150	422	711	1,106	2,398	1,335	1,230
Preferred Stock Dividends Declared	24	33	39	33	27	31	42	33	44	42
Basic Earnings per Share	$5.24	$7.13	$9.51	$8.38	$6.05	$5.33	$5.71	$3.68	$3.54	$2.86
Weighted Average Basic Shares Outstanding	912M	908M	916M	923M	921M	936M	970M	991M	1.00B	1.03B
Diluted Earnings per Share	$5.20	$7.07	$9.41	$8.26	$5.97	$5.24	$5.59	$3.61	$3.48	$2.82
Weighted Average Diluted Shares Outstanding	919M	916M	926M	936M	933M	952M	990M	1.01B	1.02B	1.04B
Weighted Average Basic & Diluted Shares Outstanding	910.33M	909.29M	906.21M	923.55M	920.24M	933.98M	969.90M	991.60M	1.00B	1.03B
Cash Dividends to Common per Share	$5.26	$5.02	$4.69	$4.21	$3.72	$3.21	$2.63	$2.12	$1.64	$1.40

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	1,173	1,199	1,355	1,121	1,100	1,365	1,699	1,714	1,699	1,953	2,284
Consolidated Net Income / (Loss)	1,179	1,205	1,362	1,127	1,105	1,371	1,709	1,722	1,708	1,962	2,295
Net Income / (Loss) Continuing Operations	1,179	1,205	1,362	1,127	1,105	1,371	1,709	1,722	1,708	1,962	2,295
Total Pre-Tax Income	1,276	1,359	1,554	1,247	1,293	1,548	1,922	2,002	1,946	2,167	2,658
Total Operating Income	1,324	1,377	1,554	1,248	1,286	1,533	1,892	1,972	1,934	2,176	2,678
Total Gross Profit	2,313	2,314	2,474	2,211	2,095	2,431	2,815	2,910	2,863	3,087	3,617
Total Revenue	4,069	4,007	4,151	3,822	3,661	4,077	4,532	4,531	4,379	4,670	5,241
Operating Revenue	4,069	4,007	4,151	3,822	3,661	4,077	4,532	4,531	4,379	4,670	5,241
Total Cost of Revenue	1,756	1,693	1,677	1,611	1,566	1,646	1,717	1,621	1,516	1,583	1,624
Operating Cost of Revenue	1,756	1,693	1,677	1,611	1,566	1,646	1,717	1,621	1,516	1,583	1,624
Total Operating Expenses	989	937	920	963	809	898	923	938	929	911	939
Selling, General & Admin Expense	472	446	428	465	455	438	452	461	474	220	508
Research & Development Expense	517	491	492	498	478	460	471	477	455	434	431
Restructuring Charge	0.00	-	0.00	0.00	-124	-	0.00	0.00	-	-	-
Total Other Income / (Expense), net	-48	-18	0.00	-1.00	7.00	15	30	30	12	-9.00	-20
Interest Expense	128	130	131	131	116	98	98	89	68	60	53
Other Income / (Expense), net	80	112	131	130	123	113	128	119	80	51	33
Income Tax Expense	97	154	192	120	188	177	213	280	238	205	363
Preferred Stock Dividends Declared	6.00	6.00	7.00	6.00	5.00	6.00	10	8.00	9.00	9.00	11
Basic Earnings per Share	$1.29	$1.32	$1.48	$1.23	$1.21	$1.50	$1.87	$1.89	$1.87	$2.16	$2.50
Weighted Average Basic Shares Outstanding	910M	912M	913M	912M	910M	908M	908M	908M	907M	916M	913M
Diluted Earnings per Share	$1.28	$1.31	$1.47	$1.22	$1.20	$1.50	$1.85	$1.87	$1.85	$2.14	$2.47
Weighted Average Diluted Shares Outstanding	916M	919M	920M	919M	917M	916M	916M	916M	916M	926M	923M
Weighted Average Basic & Diluted Shares Outstanding	908.47M	910.33M	912.22M	913.05M	910.48M	909.29M	908.20M	907.97M	907.65M	906.21M	907.57M
Cash Dividends to Common per Share	$1.36	-	$1.30	$1.30	$1.30	-	$1.24	$1.24	$1.24	-	$1.15

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	236	-86	-1,581	1,524	670	-1.00	782	502	154	-199
Net Cash From Operating Activities	6,318	6,420	8,720	8,756	6,139	6,649	7,189	5,363	4,614	4,397
Net Cash From Continuing Operating Activities	6,318	6,420	8,720	8,756	6,139	6,649	7,189	5,366	4,614	4,397
Net Income / (Loss) Continuing Operations	4,799	6,510	8,749	7,769	5,595	5,017	5,580	3,682	3,595	2,986
Consolidated Net Income / (Loss)	4,799	6,510	8,749	7,769	5,595	5,017	5,580	3,682	3,595	2,986
Depreciation Expense	1,508	1,175	925	755	733	708	590	539	605	766
Amortization Expense	72	63	54	199	259	342	364	365	350	367
Non-Cash Adjustments To Reconcile Net Income	260	362	286	173	220	194	229	242	212	201
Changes in Operating Assets and Liabilities, net	-321	-1,690	-1,294	-140	-668	388	426	538	-148	77
Net Cash From Investing Activities	-3,202	-4,362	-3,583	-4,095	-922	-1,920	-78	-1,127	-650	-302
Net Cash From Continuing Investing Activities	-3,202	-4,362	-3,583	-4,095	-922	-1,920	-78	-1,127	-650	-302
Purchase of Property, Plant & Equipment	-4,820	-5,071	-2,797	-2,462	-649	-847	-1,131	-695	-531	-551
Purchase of Investments	-9,716	-12,705	-14,483	-10,124	-5,786	-3,444	-5,641	-4,555	-3,503	-2,767
Sale of Property, Plant & Equipment	195	3.00	3.00	75	4.00	30	9.00	40	0.00	110
Sale and/or Maturity of Investments	11,187	13,387	13,657	8,478	5,545	2,309	6,708	4,095	3,390	2,892
Other Investing Activities, net	-48	24	37	-62	-36	32	-23	-12	-6.00	14
Net Cash From Financing Activities	-2,880	-2,144	-6,718	-3,137	-4,547	-4,730	-6,329	-3,734	-3,810	-4,294
Net Cash From Continuing Financing Activities	-2,880	-2,144	-6,718	-3,137	-4,547	-4,730	-6,329	-3,734	-3,810	-4,294
Repayment of Debt	-653	-557	-541	-596	-536	-792	-547	-656	-1,003	-1,003
Repurchase of Common Equity	-929	-293	-3,615	-527	-2,553	-2,960	-5,100	-2,556	-2,132	-2,741
Payment of Dividends	-4,795	-4,557	-4,297	-3,886	-3,426	-3,008	-2,555	-2,104	-1,646	-1,444
Issuance of Debt	2,980	3,000	1,494	1,495	1,498	1,491	1,500	1,099	499	498
Issuance of Common Equity	517	263	241	377	470	539	373	483	472	396

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-437	611	-151	257	-481	398	-873	-1,038	1,427	-119	-633
Net Cash From Operating Activities	849	1,998	1,732	1,571	1,017	1,924	1,937	1,399	1,160	2,042	2,766
Net Cash From Continuing Operating Activities	849	1,998	1,732	1,571	1,017	1,924	1,937	1,399	1,160	2,042	2,766
Net Income / (Loss) Continuing Operations	1,179	1,205	1,362	1,127	1,105	1,371	1,709	1,722	1,708	1,962	2,295
Consolidated Net Income / (Loss)	1,179	1,205	1,362	1,127	1,105	1,371	1,709	1,722	1,708	1,962	2,295
Depreciation Expense	424	416	383	363	346	322	303	285	265	249	249
Amortization Expense	20	19	19	18	16	15	17	15	16	14	13
Non-Cash Adjustments To Reconcile Net Income	116	77	87	119	-23	69	79	110	104	62	68
Changes in Operating Assets and Liabilities, net	-890	281	-119	-56	-427	147	-171	-733	-933	-245	141
Net Cash From Investing Activities	1,253	614	-487	-	-3,329	-311	-1,694	-2,385	28	-1,027	-2,113
Net Cash From Continuing Investing Activities	1,253	614	-487	-	-3,329	-311	-1,694	-2,385	28	-1,027	-2,113
Purchase of Property, Plant & Equipment	-1,123	-1,192	-1,316	-1,064	-1,248	-1,148	-1,495	-1,446	-982	-967	-790
Purchase of Investments	-647	-909	-1,845	-2,098	-4,864	-2,565	-3,080	-4,047	-3,013	-3,688	-4,346
Sale of Property, Plant & Equipment	0.00	1.00	-	2.00	192	-	1.00	1.00	1.00	-	-
Sale and/or Maturity of Investments	2,807	2,726	2,700	3,130	2,631	3,411	2,885	3,065	4,026	3,650	3,033
Other Investing Activities, net	216	-12	-26	30	-40	-9.00	-5.00	42	-4.00	-22	-10
Net Cash From Financing Activities	-2,539	-2,001	-1,396	-1,314	1,831	-1,215	-1,116	-52	239	-1,134	-1,286
Net Cash From Continuing Financing Activities	-2,539	-2,001	-1,396	-1,314	1,831	-1,215	-1,116	-52	239	-1,134	-1,286
Repayment of Debt	-766	-311	-8.00	-306	-28	-14	-12	-516	-15	-12	-12
Repurchase of Common Equity	-653	-537	-318	-71	-3.00	-65	-46	-79	-103	-848	-996
Payment of Dividends	-1,238	-1,240	-1,187	-1,185	-1,183	-1,181	-1,126	-1,125	-1,125	-1,123	-1,051
Issuance of Debt	0.00	-	-	-	2,980	-	-	1,603	1,397	799	695
Issuance of Common Equity	118	87	117	248	65	45	68	65	85	50	78

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	35,509	32,348	27,207	24,676	19,351	18,018	17,137	17,642	16,431	16,230
Total Current Assets	15,026	15,122	14,021	13,685	10,239	8,761	8,097	8,734	7,457	7,074
Cash & Equivalents	3,200	2,964	3,050	4,631	3,107	2,437	2,438	1,656	1,154	1,000
Short-Term Investments	4,380	5,611	6,017	5,108	3,461	2,950	1,795	2,813	2,336	2,218
Accounts Receivable	1,719	1,787	1,895	1,701	1,414	1,074	1,207	1,278	1,267	1,165
Inventories, net	4,527	3,999	2,757	1,910	1,955	2,001	2,217	1,957	1,790	1,691
Prepaid Expenses	1,200	761	302	335	302	299	440	1,030	910	1,000
Plant, Property, & Equipment, net	11,347	9,999	6,876	5,141	3,269	3,303	3,183	2,664	2,512	2,596
Plant, Property & Equipment, gross	15,254	13,268	9,950	7,858	5,781	5,740	5,425	4,789	4,923	5,465
Accumulated Depreciation	3,907	3,269	3,074	2,717	2,512	2,437	2,242	2,125	2,411	2,869
Total Noncurrent Assets	9,136	7,227	6,310	5,850	5,843	5,954	5,857	6,244	6,462	6,560
Goodwill	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362
Intangible Assets	257	223	152	85	122	409	717	1,056	1,316	1,629
Noncurrent Deferred & Refundable Income Taxes	936	757	473	263	343	197	295	264	374	201
Employee Benefit Assets	233	173	188	392	246	218	92	208	96	85
Other Noncurrent Operating Assets	3,348	1,712	1,135	748	770	468	140	86	79	62
Total Liabilities & Shareholders' Equity	35,509	32,348	27,207	24,676	19,351	18,018	17,137	17,642	16,431	16,230
Total Liabilities	18,606	15,451	12,630	11,343	10,164	9,111	8,143	7,305	5,958	6,284
Total Current Liabilities	3,643	3,320	2,985	2,569	2,390	2,123	2,474	2,258	2,264	2,555
Short-Term Debt	750	599	500	500	550	500	749	500	631	1,000
Accounts Payable	820	802	851	571	415	388	478	466	396	386
Current Deferred & Payable Income Tax Liabilities	159	172	189	121	134	46	103	128	83	95
Current Employee Benefit Liabilities	839	836	799	775	767	714	724	722	710	664
Other Current Liabilities	1,075	911	646	602	524	475	420	442	444	410
Total Noncurrent Liabilities	14,963	12,131	9,645	8,774	7,774	6,988	5,669	5,047	3,694	3,729
Long-Term Debt	12,846	10,624	8,235	7,241	6,248	5,303	4,319	3,577	2,978	3,120
Noncurrent Deferred & Payable Income Tax Liabilities	53	63	66	87	90	78	42	78	33	37
Noncurrent Employee Benefit Liabilities	110	108	118	79	131	93	118	89	129	196
Other Noncurrent Operating Liabilities	1,954	1,336	1,226	1,367	1,305	1,514	1,190	1,303	554	-
Total Equity & Noncontrolling Interests	16,903	16,897	14,577	13,333	9,187	8,907	8,994	10,337	10,473	9,946
Total Preferred & Common Equity	16,903	16,897	14,577	13,333	9,187	8,907	8,994	10,337	10,473	9,946
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	16,903	16,897	14,577	13,333	9,187	8,907	8,994	10,337	10,473	9,946
Common Stock	5,676	5,103	4,692	4,371	4,074	3,851	3,691	3,517	3,415	3,370
Retained Earnings	52,262	52,283	50,353	45,919	42,051	39,898	37,906	34,662	33,107	31,176
Treasury Stock	-40,895	-40,284	-40,214	-36,800	-36,578	-34,495	-32,130	-27,458	-25,523	-24,068
Accumulated Other Comprehensive Income / (Loss)	-140	-205	-254	-157	-360	-347	-473	-384	-526	-532

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	33,757	35,509	35,321	35,048	34,885	32,348	31,638	30,939	29,220	27,207	26,057
Total Current Assets	13,086	15,026	15,872	16,789	17,448	15,122	15,097	15,514	15,023	14,021	13,772
Cash & Equivalents	2,763	3,200	2,589	2,740	2,483	2,964	2,566	3,439	4,477	3,050	3,169
Short-Term Investments	2,242	4,380	6,163	6,948	7,910	5,611	6,382	6,113	5,068	6,017	5,921
Accounts Receivable	1,860	1,719	1,862	1,711	1,671	1,787	1,976	1,956	1,877	1,895	2,040
Inventories, net	4,687	4,527	4,296	4,106	4,083	3,999	3,908	3,729	3,288	2,757	2,404
Prepaid Expenses	1,534	1,200	962	1,284	1,301	761	265	277	313	302	238
Plant, Property, & Equipment, net	11,811	11,347	11,802	11,174	10,442	9,999	9,320	8,525	7,665	6,876	6,485
Plant, Property & Equipment, gross	16,036	15,254	15,464	14,622	13,739	13,268	12,528	11,664	10,791	9,950	9,491
Accumulated Depreciation	4,225	3,907	3,662	3,448	3,297	3,269	3,208	3,139	3,126	3,074	3,006
Total Noncurrent Assets	8,860	9,136	7,647	7,085	6,995	7,227	7,221	6,900	6,532	6,310	5,800
Goodwill	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362
Intangible Assets	263	257	229	230	231	223	138	143	140	152	75
Noncurrent Deferred & Refundable Income Taxes	1,030	936	941	905	821	757	632	537	486	473	291
Employee Benefit Assets	240	233	184	167	169	173	166	183	189	188	273
Other Noncurrent Operating Assets	2,965	3,348	1,931	1,421	1,412	1,712	1,923	1,675	1,355	1,135	799
Total Liabilities & Shareholders' Equity	33,757	35,509	35,321	35,048	34,885	32,348	31,638	30,939	29,220	27,207	26,057
Total Liabilities	17,351	18,606	18,053	17,834	17,902	15,451	15,007	14,999	13,977	12,630	11,550
Total Current Liabilities	2,489	3,643	3,686	3,637	3,553	3,320	2,652	2,711	2,904	2,985	2,798
Short-Term Debt	0.00	750	1,049	1,049	1,349	599	300	299	500	500	499
Accounts Payable	866	820	794	858	551	802	713	923	952	851	780
Current Deferred & Payable Income Tax Liabilities	284	159	108	178	378	172	108	121	372	189	123
Current Employee Benefit Liabilities	418	839	721	569	399	836	707	561	394	799	662
Other Current Liabilities	921	1,075	1,014	983	876	911	824	807	686	646	734
Total Noncurrent Liabilities	14,862	14,963	14,367	14,197	14,349	12,131	12,355	12,288	11,073	9,645	8,752
Long-Term Debt	12,848	12,846	12,844	12,842	12,840	10,624	10,922	10,920	9,626	8,235	7,438
Noncurrent Deferred & Payable Income Tax Liabilities	56	53	54	55	55	63	66	69	73	66	92
Noncurrent Employee Benefit Liabilities	115	110	117	113	111	108	141	127	123	118	69
Other Noncurrent Operating Liabilities	1,843	1,954	1,352	1,187	1,343	1,336	1,226	1,172	1,251	1,226	1,153
Total Equity & Noncontrolling Interests	16,406	16,903	17,268	17,214	16,983	16,897	16,631	15,940	15,243	14,577	14,507
Total Preferred & Common Equity	16,406	16,903	17,268	17,214	16,983	16,897	16,631	15,940	15,243	14,577	14,507
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	16,406	16,903	17,268	17,214	16,983	16,897	16,631	15,940	15,243	14,577	14,507
Common Stock	5,799	5,676	5,554	5,407	5,180	5,103	5,021	4,904	4,757	4,692	4,618
Retained Earnings	52,196	52,262	52,304	52,135	52,199	52,283	52,098	51,522	50,930	50,353	49,519
Treasury Stock	-41,442	-40,895	-40,395	-40,128	-40,193	-40,284	-40,253	-40,240	-40,192	-40,214	-39,476
Accumulated Other Comprehensive Income / (Loss)	-147	-140	-195	-200	-203	-205	-235	-246	-252	-254	-154

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-10.72%	-12.53%	9.18%	26.85%	0.54%	-8.88%	5.50%	11.90%	2.85%	-0.35%
EBITDA Growth	-16.29%	-19.74%	11.61%	39.70%	3.61%	-10.52%	9.95%	18.39%	9.67%	4.64%
EBIT Growth	-23.29%	-24.16%	12.56%	46.66%	5.24%	-13.40%	10.60%	22.91%	16.35%	8.52%
NOPAT Growth	-25.24%	-27.25%	13.31%	42.41%	9.34%	-10.53%	52.09%	4.05%	15.66%	6.50%
Net Income Growth	-26.28%	-25.59%	12.61%	38.86%	11.52%	-10.09%	51.55%	2.42%	20.40%	5.85%
EPS Growth	-26.45%	-24.87%	13.92%	38.36%	13.93%	-6.26%	54.85%	3.74%	23.40%	9.73%
Operating Cash Flow Growth	-1.59%	-26.38%	-0.41%	42.63%	-7.67%	-7.51%	34.05%	16.23%	4.94%	8.46%
Free Cash Flow Firm Growth	26.63%	-80.89%	0.79%	15.73%	-8.64%	-2.35%	30.65%	14.53%	3.26%	4.29%
Invested Capital Growth	17.26%	37.21%	25.67%	20.37%	4.37%	-5.79%	-1.02%	-6.57%	-2.54%	-5.59%
Revenue Q/Q Growth	-0.45%	-3.27%	-0.80%	4.30%	5.29%	-2.49%	-0.21%	2.30%	1.71%	-0.61%
EBITDA Q/Q Growth	-0.78%	-5.33%	-2.05%	5.31%	10.19%	-3.29%	-0.09%	0.74%	5.69%	0.15%
EBIT Q/Q Growth	-2.57%	-6.96%	-2.71%	6.27%	12.16%	-3.86%	-0.47%	0.90%	7.63%	1.22%
NOPAT Q/Q Growth	-2.77%	-8.68%	-2.23%	8.09%	10.47%	-3.60%	19.11%	-13.48%	1.49%	1.24%
Net Income Q/Q Growth	-3.34%	-8.32%	-1.97%	6.15%	12.42%	-3.26%	19.10%	-16.03%	6.24%	0.37%
EPS Q/Q Growth	-3.53%	-8.30%	-1.36%	6.03%	12.64%	-2.42%	19.44%	-15.65%	6.75%	1.81%
Operating Cash Flow Q/Q Growth	1.19%	-1.80%	-3.49%	2.72%	6.43%	-5.55%	3.10%	11.24%	-3.59%	2.93%
Free Cash Flow Firm Q/Q Growth	-0.48%	-24.14%	2.31%	-11.73%	5.42%	-6.75%	5.96%	11.44%	-7.35%	2.97%
Invested Capital Q/Q Growth	2.28%	3.39%	6.67%	12.14%	-1.46%	-4.22%	-6.02%	-10.97%	-1.61%	-4.70%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.14%	62.90%	68.76%	67.47%	64.10%	63.71%	65.11%	64.26%	61.76%	58.27%
EBITDA Margin	48.21%	51.42%	56.05%	54.82%	49.78%	48.31%	49.20%	47.20%	44.61%	41.84%
Operating Margin	34.94%	41.85%	50.63%	48.84%	40.76%	39.79%	42.53%	40.66%	36.31%	33.25%
EBIT Margin	38.11%	44.36%	51.16%	49.62%	42.92%	41.01%	43.15%	41.16%	37.47%	33.12%
Profit (Net Income) Margin	30.68%	37.16%	43.68%	42.35%	38.69%	34.88%	35.35%	24.61%	26.89%	22.97%
Tax Burden Percent	88.01%	87.76%	87.21%	87.11%	92.99%	87.59%	83.46%	60.56%	72.92%	70.83%
Interest Burden Percent	91.48%	95.46%	97.91%	97.98%	96.94%	97.12%	98.16%	98.73%	98.40%	97.91%
Effective Tax Rate	11.99%	12.24%	12.79%	12.89%	7.01%	12.41%	16.54%	39.44%	27.08%	29.17%
Return on Invested Capital (ROIC)	22.65%	38.08%	69.14%	75.22%	59.44%	53.90%	58.19%	36.78%	33.74%	27.98%
ROIC Less NNEP Spread (ROIC-NNEP)	22.41%	44.67%	77.23%	79.26%	125.55%	55.15%	117.49%	37.24%	53.10%	18.27%
Return on Net Nonoperating Assets (RNNOA)	5.74%	3.29%	-6.45%	-6.22%	2.40%	2.16%	-0.46%	-1.39%	1.47%	1.39%
Return on Equity (ROE)	28.40%	41.37%	62.69%	69.00%	61.84%	56.05%	57.73%	35.39%	35.21%	29.37%
Cash Return on Invested Capital (CROIC)	6.76%	6.71%	46.39%	56.73%	55.17%	59.86%	59.22%	43.56%	36.32%	33.73%
Operating Return on Assets (OROA)	17.57%	26.10%	39.50%	41.35%	33.22%	33.55%	39.17%	36.15%	30.68%	25.63%
Return on Assets (ROA)	14.14%	21.86%	33.73%	35.29%	29.94%	28.54%	32.09%	21.61%	22.01%	17.77%
Return on Common Equity (ROCE)	28.40%	41.37%	62.69%	69.00%	61.84%	56.05%	57.73%	35.39%	35.21%	29.37%
Return on Equity Simple (ROE_SIMPLE)	28.39%	38.53%	60.02%	58.27%	60.90%	56.33%	62.04%	35.62%	34.33%	30.02%
Net Operating Profit after Tax (NOPAT)	4,810	6,434	8,843	7,805	5,481	5,013	5,603	3,684	3,540	3,061
NOPAT Margin	30.75%	36.72%	44.15%	42.55%	37.90%	34.85%	35.50%	24.62%	26.48%	23.55%
Net Nonoperating Expense Percent (NNEP)	0.24%	-6.59%	-8.08%	-4.04%	-66.11%	-1.25%	-59.30%	-0.47%	-19.36%	9.71%
Return On Investment Capital (ROIC_SIMPLE)	15.77%	22.88%	37.93%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	41.86%	37.10%	31.24%	32.53%	35.90%	36.29%	34.89%	35.74%	38.24%	41.73%
SG&A Expenses to Revenue	11.47%	10.42%	8.51%	9.38%	11.39%	11.44%	10.67%	11.32%	13.03%	13.29%
R&D to Revenue	12.52%	10.63%	8.34%	8.47%	10.58%	10.73%	9.88%	10.08%	10.14%	9.75%
Operating Expenses to Revenue	23.20%	21.05%	18.13%	18.62%	23.34%	23.92%	22.58%	23.60%	25.45%	25.02%
Earnings before Interest and Taxes (EBIT)	5,961	7,771	10,246	9,103	6,207	5,898	6,811	6,158	5,010	4,306
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	7,541	9,009	11,225	10,057	7,199	6,948	7,765	7,062	5,965	5,439
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	10.05	8.84	9.63	12.05	14.79	11.79	8.60	8.27	5.64	4.41
Price to Tangible Book Value (P/TBV)	13.82	12.14	13.94	18.08	28.88	25.40	19.75	17.38	12.32	11.09
Price to Revenue (P/Rev)	10.86	8.53	7.01	8.76	9.39	7.30	4.90	5.71	4.42	3.37
Price to Earnings (P/E)	35.56	23.07	16.11	20.76	24.40	21.07	13.96	23.42	16.63	14.90
Dividend Yield	2.83%	3.05%	3.03%	2.42%	2.51%	2.86%	3.27%	2.44%	2.77%	3.24%
Earnings Yield	2.81%	4.33%	6.21%	4.82%	4.10%	4.75%	7.16%	4.27%	6.01%	6.71%
Enterprise Value to Invested Capital (EV/IC)	7.67	7.78	9.83	13.99	14.45	11.65	8.14	8.76	5.69	4.19
Enterprise Value to Revenue (EV/Rev)	11.24	8.68	6.99	8.65	9.41	7.31	4.94	5.67	4.41	3.43
Enterprise Value to EBITDA (EV/EBITDA)	23.31	16.88	12.47	15.77	18.90	15.13	10.03	12.01	9.88	8.19
Enterprise Value to EBIT (EV/EBIT)	29.49	19.57	13.66	17.43	21.92	17.83	11.44	13.77	11.77	10.34
Enterprise Value to NOPAT (EV/NOPAT)	36.55	23.64	15.83	20.32	24.83	20.98	13.91	23.02	16.65	14.55
Enterprise Value to Operating Cash Flow (EV/OCF)	27.83	23.69	16.05	18.12	22.16	15.81	10.84	15.82	12.78	10.13
Enterprise Value to Free Cash Flow (EV/FCFF)	122.47	134.14	23.59	26.95	26.75	18.89	13.67	19.44	15.47	12.07
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.80	0.66	0.60	0.58	0.74	0.65	0.56	0.39	0.34	0.41
Long-Term Debt to Equity	0.76	0.63	0.56	0.54	0.68	0.60	0.48	0.35	0.28	0.31
Financial Leverage	0.26	0.07	-0.08	-0.08	0.02	0.04	0.00	-0.04	0.03	0.08
Leverage Ratio	2.01	1.89	1.86	1.96	2.07	1.96	1.80	1.64	1.60	1.65
Compound Leverage Factor	1.84	1.81	1.82	1.92	2.00	1.91	1.77	1.62	1.57	1.62
Debt to Total Capital	44.58%	39.91%	37.47%	36.73%	42.53%	39.45%	36.04%	28.29%	25.63%	29.29%
Short-Term Debt to Total Capital	2.46%	2.13%	2.14%	2.37%	3.44%	3.40%	5.33%	3.47%	4.48%	7.11%
Long-Term Debt to Total Capital	42.12%	37.78%	35.33%	34.36%	39.09%	36.05%	30.71%	24.82%	21.15%	22.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	55.42%	60.09%	62.53%	63.27%	57.47%	60.55%	63.96%	71.72%	74.37%	70.71%
Debt to EBITDA	1.80	1.25	0.78	0.77	0.94	0.84	0.65	0.58	0.61	0.76
Net Debt to EBITDA	0.80	0.29	-0.03	-0.20	0.03	0.02	0.08	-0.09	-0.02	0.13
Long-Term Debt to EBITDA	1.70	1.18	0.73	0.72	0.87	0.76	0.56	0.51	0.50	0.57
Debt to NOPAT	2.83	1.74	0.99	0.99	1.24	1.16	0.90	1.11	1.02	1.35
Net Debt to NOPAT	1.25	0.41	-0.04	-0.26	0.04	0.02	0.10	-0.18	-0.03	0.22
Long-Term Debt to NOPAT	2.67	1.65	0.93	0.93	1.14	1.06	0.77	0.97	0.84	1.02
Altman Z-Score	8.92	9.84	11.72	13.60	13.35	12.34	11.42	12.21	10.97	8.89
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.12	4.55	4.70	5.33	4.28	4.13	3.27	3.87	3.29	2.77
Quick Ratio	2.55	3.12	3.67	4.45	3.34	3.04	2.20	2.55	2.10	1.72
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,436	1,134	5,933	5,887	5,087	5,568	5,702	4,364	3,810	3,690
Operating Cash Flow to CapEx	136.61%	126.68%	312.10%	366.82%	951.78%	813.83%	640.73%	818.78%	868.93%	997.05%
Free Cash Flow to Firm to Interest Expense	2.83	3.21	27.73	31.99	26.77	32.75	45.61	55.95	47.63	41.00
Operating Cash Flow to Interest Expense	12.44	18.19	40.75	47.59	32.31	39.11	57.51	68.76	57.68	48.86
Operating Cash Flow Less CapEx to Interest Expense	3.33	3.83	27.69	34.61	28.92	34.31	48.54	60.36	51.04	43.96
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.59	0.77	0.83	0.77	0.82	0.91	0.88	0.82	0.77
Accounts Receivable Turnover	8.92	9.52	11.14	11.78	11.62	12.61	12.70	11.76	11.00	10.78
Inventory Turnover	1.54	1.92	2.68	3.09	2.62	2.47	2.64	2.85	2.94	3.12
Fixed Asset Turnover	1.47	2.08	3.33	4.36	4.40	4.44	5.40	5.78	5.23	4.78
Accounts Payable Turnover	8.07	7.86	8.80	12.11	12.93	12.05	11.67	12.41	13.08	13.18
Days Sales Outstanding (DSO)	40.91	38.36	32.77	30.99	31.40	28.94	28.73	31.04	33.20	33.85
Days Inventory Outstanding (DIO)	237.67	189.69	136.12	118.19	139.05	147.50	138.32	127.89	124.25	116.90
Days Payable Outstanding (DPO)	45.21	46.41	41.48	30.15	28.23	30.28	31.28	29.42	27.91	27.69
Cash Conversion Cycle (CCC)	233.36	181.63	127.42	119.03	142.23	146.16	135.77	129.51	129.53	123.06
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	22,919	19,545	14,245	11,335	9,417	9,023	9,578	9,677	10,357	10,627
Invested Capital Turnover	0.74	1.04	1.57	1.77	1.57	1.55	1.64	1.49	1.27	1.19
Increase / (Decrease) in Invested Capital	3,374	5,300	2,910	1,918	394	-555	-99	-680	-270	-629
Enterprise Value (EV)	175,810	152,067	139,990	158,627	136,070	105,150	77,917	84,816	58,954	44,534
Market Capitalization	169,794	149,419	140,322	160,625	135,840	105,034	77,333	85,476	59,070	43,853
Book Value per Share	$18.53	$18.60	$16.06	$14.44	$10.01	$9.53	$9.36	$10.49	$10.48	$9.80
Tangible Book Value per Share	$13.47	$13.56	$11.09	$9.62	$5.12	$4.42	$4.08	$4.99	$4.80	$3.90
Total Capital	30,499	28,120	23,312	21,074	15,985	14,710	14,062	14,414	14,082	14,066
Total Debt	13,596	11,223	8,735	7,741	6,798	5,803	5,068	4,077	3,609	4,120
Total Long-Term Debt	12,846	10,624	8,235	7,241	6,248	5,303	4,319	3,577	2,978	3,120
Net Debt	6,016	2,648	-332	-1,998	230	116	584	-660	-116	681
Capital Expenditures (CapEx)	4,625	5,068	2,794	2,387	645	817	1,122	655	531	441
Debt-free, Cash-free Net Working Capital (DFCFNWC)	4,553	3,826	2,469	1,877	1,831	1,751	2,139	2,507	2,334	2,301
Debt-free Net Working Capital (DFNWC)	12,133	12,401	11,536	11,616	8,399	7,138	6,372	6,976	5,824	5,519
Net Working Capital (NWC)	11,383	11,802	11,036	11,116	7,849	6,638	5,623	6,476	5,193	4,519
Net Nonoperating Expense (NNE)	11	-76	94	36	-114	-4.38	23	1.82	-55	75
Net Nonoperating Obligations (NNO)	6,016	2,648	-332	-1,998	230	116	584	-660	-116	681
Total Depreciation and Amortization (D&A)	1,580	1,238	979	954	992	1,050	954	904	955	1,133
Debt-free, Cash-free Net Working Capital to Revenue	29.11%	21.84%	12.33%	10.23%	12.66%	12.17%	13.55%	16.76%	17.46%	17.70%
Debt-free Net Working Capital to Revenue	77.57%	70.79%	57.60%	63.32%	58.08%	49.63%	40.37%	46.63%	43.56%	42.45%
Net Working Capital to Revenue	72.78%	67.37%	55.10%	60.60%	54.28%	46.15%	35.62%	43.29%	38.84%	34.76%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.24	$7.13	$9.51	$8.38	$6.05	$5.33	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	912M	908M	916M	923M	921M	936M	0.00	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$5.20	$7.07	$9.41	$8.26	$5.97	$5.24	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	919M	916M	926M	936M	933M	952M	0.00	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	910.33M	909.29M	906.21M	923.55M	920.24M	933.98M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	4,700	6,434	9,067	7,805	5,481	4,981	5,870	3,883	3,762	3,244
Normalized NOPAT Margin	30.05%	36.72%	45.27%	42.55%	37.90%	34.63%	37.19%	25.95%	28.14%	24.95%
Pre Tax Income Margin	34.86%	42.34%	50.09%	48.62%	41.61%	39.82%	42.36%	40.64%	36.87%	32.43%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.73	22.01	47.88	49.47	32.67	34.69	54.49	78.95	62.63	47.84
NOPAT to Interest Expense	9.47	18.23	41.32	42.42	28.85	29.49	44.82	47.23	44.25	34.01
EBIT Less CapEx to Interest Expense	2.63	7.66	34.82	36.50	29.27	29.89	45.51	70.55	55.99	42.94
NOPAT Less CapEx to Interest Expense	0.36	3.87	28.27	29.44	25.45	24.68	35.84	38.83	37.62	29.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	99.92%	70.00%	49.11%	50.02%	61.23%	59.96%	45.79%	57.14%	45.79%	48.36%
Augmented Payout Ratio	119.27%	74.50%	90.43%	56.80%	106.86%	118.96%	137.19%	126.56%	105.09%	140.15%

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.14%	-1.72%	-8.41%	-15.65%	-16.40%	-12.70%	-13.53%	-13.07%	-10.72%	-3.35%	12.88%
EBITDA Growth	4.35%	-2.98%	-10.81%	-26.43%	-22.83%	-20.36%	-21.29%	-19.49%	-17.80%	-8.62%	15.55%
EBIT Growth	-0.35%	-9.54%	-16.58%	-34.10%	-30.04%	-26.09%	-25.49%	-23.41%	-21.88%	-11.35%	16.85%
NOPAT Growth	11.31%	-10.07%	-19.04%	-33.50%	-35.26%	-31.09%	-27.24%	-27.10%	-23.99%	-9.32%	17.21%
Net Income Growth	6.70%	-12.11%	-20.30%	-34.55%	-35.30%	-30.12%	-25.53%	-24.84%	-22.40%	-8.23%	17.87%
EPS Growth	6.67%	-12.67%	-20.54%	-34.76%	-35.14%	-29.91%	-25.10%	-23.67%	-21.28%	-5.73%	19.32%
Operating Cash Flow Growth	-16.52%	3.85%	-10.58%	12.29%	-12.33%	-5.78%	-29.97%	-20.87%	-45.90%	-13.36%	13.92%
Free Cash Flow Firm Growth	41.74%	45.39%	44.63%	9.44%	-75.87%	-319.46%	-314.32%	-387.05%	-7,598.53%	-468.97%	-165.68%
Invested Capital Growth	16.70%	17.26%	18.53%	21.64%	31.31%	37.21%	41.57%	35.97%	32.60%	25.67%	32.11%
Revenue Q/Q Growth	1.55%	-3.47%	8.61%	4.40%	-10.20%	-10.04%	0.02%	3.47%	-6.23%	-10.89%	0.56%
EBITDA Q/Q Growth	-3.95%	-7.81%	18.65%	-0.68%	-10.69%	-15.26%	-2.13%	4.18%	-7.83%	-16.25%	0.10%
EBIT Q/Q Growth	-5.71%	-11.63%	22.28%	-2.20%	-14.40%	-18.51%	-3.40%	3.82%	-9.56%	-17.85%	-0.70%
NOPAT Q/Q Growth	0.20%	-10.36%	20.76%	2.63%	-19.05%	-19.30%	-0.82%	-0.07%	-13.84%	-14.80%	-0.63%
Net Income Q/Q Growth	-2.16%	-11.53%	20.85%	1.99%	-19.40%	-19.78%	-0.75%	0.82%	-12.95%	-14.51%	0.17%
EPS Q/Q Growth	-2.29%	-10.88%	20.49%	1.67%	-20.00%	-18.92%	-1.07%	1.08%	-13.55%	-13.36%	0.82%
Operating Cash Flow Q/Q Growth	-57.51%	15.36%	10.25%	54.47%	-47.14%	-0.67%	38.46%	20.60%	-43.19%	-26.18%	56.45%
Free Cash Flow Firm Q/Q Growth	-4.35%	-0.52%	20.14%	30.44%	2.19%	-1.90%	-30.62%	-35.09%	-133.29%	-0.66%	-53.55%
Invested Capital Q/Q Growth	5.80%	2.28%	4.63%	3.07%	6.31%	3.39%	7.37%	11.27%	11.08%	6.67%	3.13%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.84%	57.75%	59.60%	57.85%	57.22%	59.63%	62.11%	64.22%	65.38%	66.10%	69.01%
EBITDA Margin	45.42%	48.02%	50.28%	46.02%	48.37%	48.64%	51.63%	52.77%	52.41%	53.32%	56.73%
Operating Margin	32.54%	34.36%	37.44%	32.65%	35.13%	37.60%	41.75%	43.52%	44.17%	46.60%	51.10%
EBIT Margin	34.50%	37.16%	40.59%	36.05%	38.49%	40.37%	44.57%	46.15%	45.99%	47.69%	51.73%
Profit (Net Income) Margin	28.98%	30.07%	32.81%	29.49%	30.18%	33.63%	37.71%	38.00%	39.00%	42.01%	43.79%
Tax Burden Percent	92.40%	88.67%	87.64%	90.38%	85.46%	88.57%	88.92%	86.01%	87.77%	90.54%	86.34%
Interest Burden Percent	90.88%	91.27%	92.23%	90.49%	91.77%	94.05%	95.15%	95.74%	96.62%	97.31%	98.05%
Effective Tax Rate	7.60%	11.33%	12.36%	9.62%	14.54%	11.43%	11.08%	13.99%	12.23%	9.46%	13.66%
Return on Invested Capital (ROIC)	21.43%	22.45%	24.96%	24.34%	27.56%	34.53%	41.68%	46.12%	54.47%	66.06%	75.93%
ROIC Less NNEP Spread (ROIC-NNEP)	20.67%	22.08%	24.96%	24.31%	27.83%	35.68%	46.44%	55.97%	53.07%	66.76%	77.01%
Return on Net Nonoperating Assets (RNNOA)	7.21%	5.66%	5.46%	4.30%	3.78%	2.63%	1.67%	0.98%	-2.72%	-5.57%	-9.23%
Return on Equity (ROE)	28.64%	28.11%	30.41%	28.64%	31.34%	37.16%	43.36%	47.09%	51.74%	60.49%	66.70%
Cash Return on Invested Capital (CROIC)	6.50%	6.76%	6.98%	7.47%	4.81%	6.71%	9.26%	19.75%	31.83%	46.39%	49.43%
Operating Return on Assets (OROA)	16.13%	17.13%	19.05%	17.58%	20.17%	23.75%	27.98%	31.21%	32.92%	36.82%	42.34%
Return on Assets (ROA)	13.55%	13.86%	15.40%	14.38%	15.82%	19.78%	23.68%	25.70%	27.92%	32.44%	35.84%
Return on Common Equity (ROCE)	28.64%	28.11%	30.41%	28.64%	31.34%	37.16%	43.36%	47.09%	51.74%	60.49%	66.70%
Return on Equity Simple (ROE_SIMPLE)	29.70%	0.00%	28.75%	30.86%	34.78%	0.00%	42.70%	48.22%	54.16%	0.00%	61.52%
Net Operating Profit after Tax (NOPAT)	1,223	1,221	1,362	1,128	1,099	1,358	1,682	1,696	1,697	1,970	2,312
NOPAT Margin	30.07%	30.47%	32.81%	29.51%	30.02%	33.30%	37.12%	37.44%	38.76%	42.19%	44.12%
Net Nonoperating Expense Percent (NNEP)	0.76%	0.37%	0.00%	0.03%	-0.27%	-1.15%	-4.76%	-9.85%	1.40%	-0.70%	-1.08%
Return On Investment Capital (ROIC_SIMPLE)	4.18%	4.00%	-	-	-	4.83%	-	-	-	8.45%	-
Cost of Revenue to Revenue	43.16%	42.25%	40.40%	42.15%	42.78%	40.37%	37.89%	35.78%	34.62%	33.90%	30.99%
SG&A Expenses to Revenue	11.60%	11.13%	10.31%	12.17%	12.43%	10.74%	9.97%	10.17%	10.82%	4.71%	9.69%
R&D to Revenue	12.71%	12.25%	11.85%	13.03%	13.06%	11.28%	10.39%	10.53%	10.39%	9.29%	8.22%
Operating Expenses to Revenue	24.31%	23.38%	22.16%	25.20%	22.10%	22.03%	20.37%	20.70%	21.21%	19.51%	17.92%
Earnings before Interest and Taxes (EBIT)	1,404	1,489	1,685	1,378	1,409	1,646	2,020	2,091	2,014	2,227	2,711
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,848	1,924	2,087	1,759	1,771	1,983	2,340	2,391	2,295	2,490	2,973
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.97	10.05	10.92	10.22	9.19	8.84	8.42	9.87	10.57	9.63	9.18
Price to Tangible Book Value (P/TBV)	13.89	13.82	14.88	13.94	12.60	12.14	11.54	13.76	15.00	13.94	13.22
Price to Revenue (P/Rev)	10.19	10.86	12.00	10.94	9.29	8.53	7.73	8.36	8.26	7.01	6.59
Price to Earnings (P/E)	33.74	35.56	38.17	33.30	26.55	23.07	19.82	20.57	19.60	16.11	14.98
Dividend Yield	2.96%	2.83%	2.52%	2.66%	2.96%	3.05%	3.22%	2.81%	2.69%	3.03%	3.16%
Earnings Yield	2.96%	2.81%	2.62%	3.00%	3.77%	4.33%	5.05%	4.86%	5.10%	6.21%	6.67%
Enterprise Value to Invested Capital (EV/IC)	7.07	7.67	8.65	8.41	7.69	7.78	7.53	9.03	10.22	9.83	9.88
Enterprise Value to Revenue (EV/Rev)	10.68	11.24	12.33	11.20	9.52	8.68	7.86	8.45	8.29	6.99	6.54
Enterprise Value to EBITDA (EV/EBITDA)	22.50	23.31	25.49	22.94	18.84	16.88	14.95	15.67	15.07	12.47	11.52
Enterprise Value to EBIT (EV/EBIT)	28.78	29.49	31.67	27.92	22.31	19.57	17.04	17.59	16.70	13.66	12.53
Enterprise Value to NOPAT (EV/NOPAT)	34.75	36.55	39.17	34.21	27.40	23.64	20.20	20.72	19.46	15.83	14.59
Enterprise Value to Operating Cash Flow (EV/OCF)	27.87	27.83	31.03	27.94	25.47	23.69	21.76	21.59	20.90	16.05	14.61
Enterprise Value to Free Cash Flow (EV/FCFF)	117.17	122.47	134.31	123.67	181.58	134.14	95.22	52.70	36.60	23.59	22.76
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.78	0.80	0.80	0.81	0.84	0.66	0.67	0.70	0.66	0.60	0.55
Long-Term Debt to Equity	0.78	0.76	0.74	0.75	0.76	0.63	0.66	0.69	0.63	0.56	0.51
Financial Leverage	0.35	0.26	0.22	0.18	0.14	0.07	0.04	0.02	-0.05	-0.08	-0.12
Leverage Ratio	2.06	2.01	1.98	1.99	1.99	1.89	1.85	1.85	1.86	1.86	1.85
Compound Leverage Factor	1.87	1.83	1.82	1.80	1.83	1.78	1.76	1.77	1.80	1.81	1.81
Debt to Total Capital	43.92%	44.58%	44.58%	44.66%	45.52%	39.91%	40.29%	41.31%	39.91%	37.47%	35.36%
Short-Term Debt to Total Capital	0.00%	2.46%	3.37%	3.37%	4.33%	2.13%	1.08%	1.10%	1.97%	2.14%	2.22%
Long-Term Debt to Total Capital	43.92%	42.12%	41.22%	41.29%	41.19%	37.78%	39.21%	40.21%	37.94%	35.33%	33.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.08%	55.42%	55.42%	55.34%	54.48%	60.09%	59.71%	58.69%	60.09%	62.53%	64.64%
Debt to EBITDA	1.69	1.80	1.83	1.77	1.67	1.25	1.18	1.11	0.94	0.78	0.69
Net Debt to EBITDA	1.03	0.80	0.68	0.54	0.45	0.29	0.24	0.16	0.05	-0.03	-0.10
Long-Term Debt to EBITDA	1.69	1.70	1.69	1.64	1.51	1.18	1.15	1.08	0.90	0.73	0.65
Debt to NOPAT	2.60	2.83	2.81	2.64	2.43	1.74	1.59	1.46	1.22	0.99	0.88
Net Debt to NOPAT	1.59	1.25	1.04	0.80	0.65	0.41	0.32	0.22	0.07	-0.04	-0.13
Long-Term Debt to NOPAT	2.60	2.67	2.60	2.44	2.20	1.65	1.55	1.42	1.16	0.93	0.82
Altman Z-Score	8.81	8.50	9.36	9.04	8.42	9.21	9.16	9.95	10.75	10.75	11.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.26	4.12	4.31	4.62	4.91	4.55	5.69	5.72	5.17	4.70	4.92
Quick Ratio	2.76	2.55	2.88	3.13	3.40	3.12	4.12	4.24	3.93	3.67	3.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-2,247	-2,153	-2,142	-2,682	-3,856	-3,942	-3,869	-2,962	-2,193	-940	-934
Operating Cash Flow to CapEx	75.60%	167.76%	131.61%	147.93%	96.31%	167.60%	129.65%	96.82%	118.25%	211.17%	350.13%
Free Cash Flow to Firm to Interest Expense	-17.55	-16.56	-16.35	-20.47	-33.24	-40.23	-39.48	-33.28	-32.24	-15.66	-17.62
Operating Cash Flow to Interest Expense	6.63	15.37	13.22	11.99	8.77	19.63	19.77	15.72	17.06	34.03	52.19
Operating Cash Flow Less CapEx to Interest Expense	-2.14	6.21	3.18	3.89	-0.34	7.92	4.52	-0.52	2.63	17.92	37.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.46	0.47	0.49	0.52	0.59	0.63	0.68	0.72	0.77	0.82
Accounts Receivable Turnover	9.09	8.92	8.19	8.78	9.47	9.52	9.02	9.08	10.62	11.14	10.93
Inventory Turnover	1.54	1.54	1.58	1.67	1.78	1.92	2.04	2.14	2.36	2.68	2.89
Fixed Asset Turnover	1.44	1.47	1.49	1.63	1.86	2.08	2.29	2.60	2.98	3.33	3.84
Accounts Payable Turnover	9.51	8.07	8.63	7.34	8.72	7.86	8.62	7.76	7.92	8.80	8.95
Days Sales Outstanding (DSO)	40.15	40.91	44.58	41.59	38.54	38.36	40.47	40.20	34.36	32.77	33.38
Days Inventory Outstanding (DIO)	237.57	237.67	230.34	218.64	205.38	189.69	178.96	170.53	154.68	136.12	126.50
Days Payable Outstanding (DPO)	38.39	45.21	42.31	49.70	41.88	46.41	42.33	47.03	46.07	41.48	40.79
Cash Conversion Cycle (CCC)	239.34	233.36	232.61	210.53	202.04	181.63	177.09	163.70	142.97	127.42	119.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	24,249	22,919	22,409	21,417	20,779	19,545	18,905	17,607	15,824	14,245	13,354
Invested Capital Turnover	0.71	0.74	0.76	0.82	0.92	1.04	1.12	1.23	1.41	1.57	1.72
Increase / (Decrease) in Invested Capital	3,470	3,374	3,504	3,810	4,955	5,300	5,551	4,658	3,890	2,910	3,246
Enterprise Value (EV)	171,430	175,810	193,749	180,174	159,866	152,067	142,291	159,024	161,674	139,990	131,986
Market Capitalization	163,587	169,794	188,608	175,971	156,070	149,419	140,017	157,357	161,093	140,322	133,139
Book Value per Share	$18.02	$18.53	$18.91	$18.91	$18.66	$18.60	$18.32	$17.56	$16.82	$16.06	$15.88
Tangible Book Value per Share	$12.94	$13.47	$13.88	$13.86	$13.62	$13.56	$13.36	$12.60	$11.85	$11.09	$11.02
Total Capital	29,254	30,499	31,161	31,105	31,172	28,120	27,853	27,159	25,369	23,312	22,444
Total Debt	12,848	13,596	13,893	13,891	14,189	11,223	11,222	11,219	10,126	8,735	7,937
Total Long-Term Debt	12,848	12,846	12,844	12,842	12,840	10,624	10,922	10,920	9,626	8,235	7,438
Net Debt	7,843	6,016	5,141	4,203	3,796	2,648	2,274	1,667	581	-332	-1,153
Capital Expenditures (CapEx)	1,123	1,191	1,316	1,062	1,056	1,148	1,494	1,445	981	967	790
Debt-free, Cash-free Net Working Capital (DFCFNWC)	5,592	4,553	4,483	4,513	4,851	3,826	3,797	3,550	3,074	2,469	2,383
Debt-free Net Working Capital (DFNWC)	10,597	12,133	13,235	14,201	15,244	12,401	12,745	13,102	12,619	11,536	11,473
Net Working Capital (NWC)	10,597	11,383	12,186	13,152	13,895	11,802	12,445	12,803	12,119	11,036	10,974
Net Nonoperating Expense (NNE)	44	16	0.00	0.90	-5.98	-13	-27	-26	-11	8.15	17
Net Nonoperating Obligations (NNO)	7,843	6,016	5,141	4,203	3,796	2,648	2,274	1,667	581	-332	-1,153
Total Depreciation and Amortization (D&A)	444	435	402	381	362	337	320	300	281	263	262
Debt-free, Cash-free Net Working Capital to Revenue	34.84%	29.11%	28.53%	28.05%	28.87%	21.84%	20.96%	18.86%	15.76%	12.33%	11.80%
Debt-free Net Working Capital to Revenue	66.03%	77.57%	84.24%	88.25%	90.73%	70.79%	70.37%	69.61%	64.71%	57.60%	56.83%
Net Working Capital to Revenue	66.03%	72.78%	77.56%	81.73%	82.70%	67.37%	68.71%	68.03%	62.14%	55.10%	54.35%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.29	$1.32	$1.48	$1.23	$1.21	$1.50	$1.87	$1.89	$1.87	$2.16	$2.50
Adjusted Weighted Average Basic Shares Outstanding	910M	912M	913M	912M	910M	908M	908M	908M	907M	916M	913M
Adjusted Diluted Earnings per Share	$1.28	$1.31	$1.47	$1.22	$1.20	$1.50	$1.85	$1.87	$1.85	$2.14	$2.47
Adjusted Weighted Average Diluted Shares Outstanding	916M	919M	920M	919M	917M	916M	916M	916M	916M	926M	923M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	908.47M	910.33M	912.22M	913.05M	910.48M	909.29M	908.20M	907.97M	907.65M	906.21M	907.57M
Normalized Net Operating Profit after Tax (NOPAT)	1,223	1,221	1,362	1,128	993	1,358	1,682	1,696	1,697	1,970	2,312
Normalized NOPAT Margin	30.07%	30.47%	32.81%	29.51%	27.13%	33.30%	37.12%	37.44%	38.76%	42.19%	44.12%
Pre Tax Income Margin	31.36%	33.92%	37.44%	32.63%	35.32%	37.97%	42.41%	44.18%	44.44%	46.40%	50.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.97	11.45	12.86	10.52	12.15	16.80	20.61	23.49	29.62	37.12	51.15
NOPAT to Interest Expense	9.56	9.39	10.40	8.61	9.47	13.85	17.17	19.06	24.96	32.84	43.63
EBIT Less CapEx to Interest Expense	2.20	2.29	2.82	2.41	3.04	5.08	5.37	7.26	15.19	21.00	36.25
NOPAT Less CapEx to Interest Expense	0.78	0.23	0.35	0.50	0.37	2.14	1.92	2.82	10.54	16.72	28.72
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	99.53%	99.92%	95.39%	88.01%	78.13%	70.00%	63.36%	57.55%	52.80%	49.11%	47.46%
Augmented Payout Ratio	131.93%	119.27%	104.59%	91.49%	81.40%	74.50%	78.51%	83.91%	90.70%	90.43%	80.06%

Frequently Asked Questions About Texas Instruments' Financials

When does Texas Instruments's financial year end?

According to the most recent income statement we have on file, Texas Instruments' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Texas Instruments' net income changed over the last 9 years?

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $4.80 billion in 2024, rising from $2.99 billion in 2015. The previous period was $6.51 billion in 2023. Check out Texas Instruments' forecast to explore projected trends and price targets.

What is Texas Instruments's operating income?

Texas Instruments's total operating income in 2024 was $5.47 billion, based on the following breakdown:

Total Gross Profit: $9.09 billion
Total Operating Expenses: $3.63 billion

How has Texas Instruments revenue changed over the last 9 years?

Over the last 9 years, Texas Instruments' total revenue changed from $13 billion in 2015 to $15.64 billion in 2024, a change of 20.3%.

How much debt does Texas Instruments have?

Texas Instruments' total liabilities were at $18.61 billion at the end of 2024, a 20.4% increase from 2023, and a 196.1% increase since 2015.

How much cash does Texas Instruments have?

In the past 9 years, Texas Instruments' cash and equivalents has ranged from $1 billion in 2015 to $4.63 billion in 2021, and is currently $3.20 billion as of their latest financial filing in 2024.

How has Texas Instruments' book value per share changed over the last 9 years?

Over the last 9 years, Texas Instruments' book value per share changed from 9.80 in 2015 to 18.53 in 2024, a change of 89.0%.

Related Companies

This page (NASDAQ:TXN) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Texas Instruments (TXN) Financials

Frequently Asked Questions About Texas Instruments' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Texas Instruments (TXN) Financials

Annual Income Statements for Texas Instruments

Quarterly Income Statements for Texas Instruments

Annual Cash Flow Statements for Texas Instruments

Quarterly Cash Flow Statements for Texas Instruments

Annual Balance Sheets for Texas Instruments

Quarterly Balance Sheets for Texas Instruments

Annual Metrics And Ratios for Texas Instruments

Quarterly Metrics And Ratios for Texas Instruments

Frequently Asked Questions About Texas Instruments' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools